South Korea · Delayed Price · Currency is KRW Amicogen Statistics
Total Valuation
Amicogen has a market cap or net worth of KRW 89.33 billion. The enterprise value is 144.75 billion.
| Market Cap | 89.33B |
| Enterprise Value | 144.75B |
Important Dates
The next estimated earnings date is Friday, August 14, 2026.
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Amicogen has 70.45 million shares outstanding. The number of shares has increased by 3.47% in one year.
| Current Share Class | 70.45M |
| Shares Outstanding | 70.45M |
| Shares Change (YoY) | +3.47% |
| Shares Change (QoQ) | +11.99% |
| Owned by Insiders (%) | 3.70% |
| Owned by Institutions (%) | 0.32% |
| Float | 64.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.06 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.07 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.27 |
| Interest Coverage | -2.09 |
Financial Efficiency
Return on equity (ROE) is -3.99% and return on invested capital (ROIC) is -8.52%.
| Return on Equity (ROE) | -3.99% |
| Return on Assets (ROA) | -4.16% |
| Return on Invested Capital (ROIC) | -8.52% |
| Return on Capital Employed (ROCE) | -9.41% |
| Weighted Average Cost of Capital (WACC) | 7.01% |
| Revenue Per Employee | 184.07M |
| Profits Per Employee | -19.24M |
| Employee Count | 236 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 3.63 |
Taxes
In the past 12 months, Amicogen has paid 1.24 billion in taxes.
| Income Tax | 1.24B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -66.54% in the last 52 weeks. The beta is 0.14, so Amicogen's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -66.54% |
| 50-Day Moving Average | 1,725.22 |
| 200-Day Moving Average | 2,388.21 |
| Relative Strength Index (RSI) | 29.64 |
| Average Volume (20 Days) | 591,911 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Amicogen had revenue of KRW 43.44 billion and -4.54 billion in losses. Loss per share was -79.80.
| Revenue | 43.44B |
| Gross Profit | 6.41B |
| Operating Income | -16.23B |
| Pretax Income | -3.96B |
| Net Income | -4.54B |
| EBITDA | -6.28B |
| EBIT | -16.23B |
| Loss Per Share | -79.80 |
Balance Sheet
The company has 7.81 billion in cash and 62.28 billion in debt, with a net cash position of -54.47 billion or -773.09 per share.
| Cash & Cash Equivalents | 7.81B |
| Total Debt | 62.28B |
| Net Cash | -54.47B |
| Net Cash Per Share | -773.09 |
| Equity (Book Value) | 133.35B |
| Book Value Per Share | 2,143.45 |
| Working Capital | 2.88B |
Cash Flow
In the last 12 months, operating cash flow was -47.59 billion and capital expenditures -1.33 billion, giving a free cash flow of -48.92 billion.
| Operating Cash Flow | -47.59B |
| Capital Expenditures | -1.33B |
| Depreciation & Amortization | 9.96B |
| Net Borrowing | -36.03B |
| Free Cash Flow | -48.92B |
| FCF Per Share | -694.36 |
Margins
Gross margin is 14.75%, with operating and profit margins of -37.37% and -10.45%.
| Gross Margin | 14.75% |
| Operating Margin | -37.37% |
| Pretax Margin | -9.12% |
| Profit Margin | -10.45% |
| EBITDA Margin | -14.45% |
| EBIT Margin | -37.37% |
| FCF Margin | n/a |
Dividends & Yields
Amicogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.47% |
| Shareholder Yield | -3.47% |
| Earnings Yield | -5.08% |
| FCF Yield | -54.76% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Dec 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Amicogen has an Altman Z-Score of 0.88 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.88 |
| Piotroski F-Score | 2 |